The DNA damage response - from cell biology to human disease

Abstract

Maintenance of DNA integrity is crucial for faithful transmission of the genetic code from generation to generation. Our genetic code is constantly under attack from both endogenous and exogenous sources of DNA damage. To ensure genome stability, cells have developed elegant DNA damage repair mechanisms. Defects in DNA damage repair have been linked to several human diseases including promoting oncogenesis, heritable neurodegenerative and neuromuscular diseases caused by unstable DNA repeats, neuropathies and myopathies caused by mutations and rearrangements in mitochondrial DNA, neuropsychiatric disorders, and heritable premature aging syndromes. This review will discuss our current understanding of how these underlying errors in DNA repair contribute to the clinical outcomes of patients who present with these diseases.

Keywords

DNA damage response / DNA damage repair / mutagenesis / cancer / neurodegeneration / neuropsychiatric disorders / premature aging / clinical outcomes

References

[1] Tiwari V.DNA damage and associated DNA repair defects in disease and premature aging.Am J Hum Genet2019;105:237-57 PMCID:PMC6693886

[2] Hoeijmakers JH.DNA damage, aging, and cancer.N Engl J Med2009;361:1475-85

[3] Bont R, van Larebeke N. Endogenous DNA damage in humans: a review of quantitative data.Mutagenesis2004;19:169-85

[4] Lindahl T.Instability and decay of the primary structure of DNA.Nature1993;362:709-15

[5] Hoeijmakers JH.Genome maintenance mechanisms for preventing cancer.Nature2001;411:366-74

[6] Harper JW.The DNA damage response: ten years after.Mol Cell2007;28:739-45

[7] Haber JE.Deciphering the DNA damage response.Cell2015;162:1183-5

[8] Chatterjee N.Mechanisms of DNA damage, repair, and mutagenesis.Environ Mol Mutagen2017;58:235-63 PMCID:PMC5474181

[9] Pilié PG,Mills GB.State-of-the-art strategies for targeting the DNA damage response in cancer.Nat Rev Clin Oncol2019;16:81-104 PMCID:PMC8327299

[10] Ciccia A.The DNA damage response: making it safe to play with knives.Mol Cell2010;40:179-204 PMCID:PMC2988877

[11] Guirouilh-Barbat J,Bertrand P.Is homologous recombination really an error-free process?.Front Genet2014;5:175 PMCID:PMC4052342

[12] Paull TT,Yamazaki V,Gellert M.A critical role for histone H2AX in recruitment of repair factors to nuclear foci after DNA damage.Current Biol2000;10:886-95

[13] Lanz MC,Smolka MB.DNA damage kinase signaling: checkpoint and repair at 30 years.EMBO J2019;38:e101801 PMCID:PMC6745504

[14] Futreal PA,Shattuck-Eidens D.BRCA1 mutations in primary breast and ovarian carcinomas.Science1994;266:120-2

[15] Powell SN.Roles of BRCA1 and BRCA2 in homologous recombination, DNA replication fidelity and the cellular response to ionizing radiation.Oncogene2003;22:5784-91

[16] Garfinkel DJ.Nucleotide excision repair, genome stability, and human disease: new insight from model systems.J Biomed Biotechnol2002;2:55-60 PMCID:PMC153785

[17] Sugasawa K,Masutani C.Xeroderma pigmentosum group C protein complex is the initiator of global genome nucleotide excision repair.Mol Cell1998;2:223-32

[18] Henning KA,Iyer N.The cockayne syndrome group a gene encodes a WD repeat protein that interacts with CSB protein and a subunit of RNA polymerase II TFIIH.Cell1995;82:555-64

[19] Mellon I.Selective removal of transcription-blocking DNA damage from the transcribed strand of the mammalian DHFR gene.Cell1987;51:241-9

[20] van Gool AJ,Rademakers S.The Cockayne syndrome B protein, involved in transcription-coupled DNA repair, resides in an RNA polymerase II-containing complex.EMBO J1997;16:5955-65 PMCID:PMC1170226

[21] Kraemer KH,Scotto J.DNA repair protects against cutaneous and internal neoplasia: evidence from xeroderma pigmentosum.Carcinogenesis1984;5:511-4

[22] Wilson BT,Sutton RE.The Cockayne Syndrome Natural History (CoSyNH) study: clinical findings in 102 individuals and recommendations for care.Genet Med2016;18:483-93 PMCID:PMC4857186

[23] Lindahl T.Quality control by DNA repair.Science1999;286:1897-905

[24] Mol CD,Putnam CD,Tainer JA.DNA repair mechanisms for the recognition and removal of damaged DNA bases.Annu Rev Biophys Biomol Struct1999;28:101-28

[25] Divine KK,Crowell RE.The XRCC1 399 glutamine allele is a risk factor for adenocarcinoma of the lung.Mutat Res/DNA Rep2001;461:273-8

[26] Jiricny J.The multifaceted mismatch-repair system.Nat Rev Mol Cell Biol2006;7:335-46

[27] Umar A,Simon JA.Requirement for PCNA in DNA mismatch repair at a step preceding DNA resynthesis.Cell1996;87:65-73

[28] Fishel R.Mismatch repair.J Biol Chem2015;290:26395-403 PMCID:PMC4646297

[29] Jiricny J.Mismatch repair defects in cancer.Curr Opin Genet Dev2000;10:157-61

[30] Knipscheer P,Smogorzewska A.The Fanconi anemia pathway promotes replication-dependent DNA interstrand cross-link repair.Science2009;326:1698-701 PMCID:PMC2909596

[31] Moldovan GL.How the fanconi anemia pathway guards the genome.Annu Rev Genet2009;43:223-49 PMCID:PMC2830711

[32] Ceccaldi R,D’Andrea AD.The Fanconi anaemia pathway: new players and new functions.Nat Rev Mol Cell Biol2016;17:337-49

[33] Chen HT,Difilippantonio MJ.Response to RAG-mediated VDJ cleavage by NBS1 and gamma-H2AX.Science2000;290:1962-5 PMCID:PMC4721589

[34] Bassing CH.The cellular response to general and programmed DNA double strand breaks.DNA Repair (Amst)2004;3:781-96

[35] Moshous D,de Chasseval R.Artemis, a novel DNA Double-Strand Break Repair/V(D)J recombination protein, is mutated in human severe combined immune deficiency.Cell2001;105:177-86

[36] Keeney S,Kleckner N.Meiosis-Specific DNA double-strand breaks are catalyzed by spo11, a member of a widely conserved protein family.Cell1997;88:375-84

[37] Neale MJ.Clarifying the mechanics of DNA strand exchange in meiotic recombination.Nature2006;442:153-8 PMCID:PMC5607947

[38] Richardson C,Pandita TK.The role of the DNA double-strand break response network in meiosis.DNA Repair (Amst)2004;3:1149-64

[39] Verdun RE.Replication and protection of telomeres.Nature2007;447:924-31

[40] Lange T. Shelterin: the protein complex that shapes and safeguards human telomeres.Genes Dev2005;19:2100-10

[41] di Fagagna F, Teo SH, Jackson SP. Functional links between telomeres and proteins of the DNA-damage response.Genes Dev2004;18:1781-99

[42] Palm W.How shelterin protects mammalian telomeres.Annu Rev Genet2008;42:301-34

[43] Jackson SP.The DNA-damage response in human biology and disease.Nature2009;461:1071-8 PMCID:PMC2906700

[44] Longhese MP.DNA damage response at functional and dysfunctional telomeres.Genes Dev2008;22:125-40 PMCID:PMC2731633

[45] Sedelnikova OA,Zimonjic DB,Bonner WM.Senescing human cells and ageing mice accumulate DNA lesions with unrepairable double-strand breaks.Nat Cell Biol2004;6:168-70

[46] Negrini S,Halazonetis TD.Genomic instability - an evolving hallmark of cancer.Nat Rev Mol Cell Biol2010;11:220-8

[47] Hanahan D.Hallmarks of cancer: the next generation.Cell2011;144:646-74

[48] Chen S.Meta-analysis of BRCA1 and BRCA2 penetrance.J Clin Oncol2007;25:1329-33 PMCID:PMC2267287

[49] Fackenthal JD.Breast cancer risk associated with BRCA1 and BRCA2 in diverse populations.Nat Rev Cancer2007;7:937-48

[50] Kote-Jarai Z,Saunders E.UKGPCS CollaboratorsBRCA2 is a moderate penetrance gene contributing to young-onset prostate cancer: implications for genetic testing in prostate cancer patients.Br J Cancer2011;105:1230-4

[51] Tai YC,Parmigiani G.Breast cancer risk among male BRCA1 and BRCA2 mutation carriers.J Natl Cancer Inst2007;99:1811-4 PMCID:PMC2267289

[52] Ibrahim M,Ogunleye F.Male BRCA mutation carriers: clinical characteristics and cancer spectrum.BMC Cancer2018;18:179 PMCID:PMC5809938

[53] Levy-Lahad E.Fanconi anemia and breast cancer susceptibility meet again.Nat Genet2010;42:368-9

[54] Walsh T.Ten genes for inherited breast cancer.Cancer Cell2007;11:103-5

[55] Spry M,Pierce H.DNA repair pathways and hereditary cancer susceptibility syndromes.Front Biosci2007;12:4191-207

[56] Nalepa G.Fanconi anaemia and cancer: an intricate relationship.Nat Rev Cancer2018;18:168-85

[57] Chan SH,Li S.Spectrum of germline mutations within fanconi anemia–associated genes across populations of varying ancestry.JNCI Cancer Spectrum2021;5:pkaa117

[58] Ruggeri B,Zhang SY,Goodrow T.Benzo[a]pyrene-induced murine skin tumors exhibit frequent and characteristic G to T mutations in the p53 gene.Proc Natl Acad Sci USA1993;90:1013-7 PMCID:PMC45801

[59] Pfeifer GP.Mutational spectra of human cancer.Hum Genet2009;125:493-506 PMCID:PMC2824590

[60] Lomax ME,O’Neill P.Biological consequences of radiation-induced DNA damage: relevance to radiotherapy.Clin Oncol (R Coll Radiol)2013;25:578-85

[61] D’Errico M,Teson M.New functions of XPC in the protection of human skin cells from oxidative damage.EMBO J2006;25:4305-15 PMCID:PMC1570445

[62] Kraemer KH.Forty years of research on xeroderma pigmentosum at the US National Institutes of Health.Photochem Photobiol2015;91:452-9 PMCID:PMC4355260

[63] Carpenter DO.Exposure to chemicals and radiation during childhood and risk for cancer later in life.J Adolesc Health2013;52:S21-9

[64] Rass U,West SC.Defective DNA repair and neurodegenerative disease.Cell2007;130:991-1004

[65] Welty S,Liang Z.RAD52 is required for RNA-templated recombination repair in post-mitotic neurons.J Biol Chem2018;293:1353-62 PMCID:PMC5787811

[66] Madabhushi R,Tsai LH.DNA damage and its links to neurodegeneration.Neuron2014;83:266-82 PMCID:PMC5564444

[67] Biton S,Shiloh Y.The neurological phenotype of ataxia-telangiectasia: solving a persistent puzzle.DNA Repair (Amst)2008;7:1028-38

[68] O’Driscoll M.The role of the DNA damage response pathways in brain development and microcephaly: insight from human disorders.DNA Repair (Amst)2008;7:1039-50

[69] Kerzendorfer C.Human DNA damage response and repair deficiency syndromes: linking genomic instability and cell cycle checkpoint proficiency.DNA Repair (Amst)2009;8:1139-52

[70] Katyal S.DNA strand breaks, neurodegeneration and aging in the brain.Mech Ageing Dev2008;129:483-91 PMCID:PMC3831510

[71] Waltes R,Gatei M.Human RAD50 deficiency in a Nijmegen breakage syndrome-like disorder.Am J Hum Genet2009;84:605-16 PMCID:PMC2681000

[72] Shull ER,Nakane H.Differential DNA damage signaling accounts for distinct neural apoptotic responses in ATLD and NBS.Genes Dev2009;23:171-80 PMCID:PMC2648541

[73] Otake M.Radiation-related brain damage and growth retardation among the prenatally exposed atomic bomb survivors.Int J Radiat Biol1998;74:159-71

[74] Reynolds JJ.A single strand that links multiple neuropathologies in human disease.Brain2013;136:14-27

[75] Takashima H,John J.Mutation of TDP1, encoding a topoisomerase I-dependent DNA damage repair enzyme, in spinocerebellar ataxia with axonal neuropathy.Nat Genet2002;32:267-72

[76] El-Khamisy SF,Weinfeld M.Defective DNA single-strand break repair in spinocerebellar ataxia with axonal neuropathy-1.Nature2005;434:108-13

[77] Moreira MC,Tachi N.The gene mutated in ataxia-ocular apraxia 1 encodes the new HIT/Zn-finger protein aprataxin.Nat Genet2001;29:189-93

[78] Inlora J,Khodadadi H.Identification of a novel mutation in the.APTX3:a002014 PMCID:PMC5701303

[79] Harris JL,Taucher-Scholz G,Becherel OJ.Aprataxin, poly-ADP ribose polymerase 1 (PARP-1) and apurinic endonuclease 1 (APE1) function together to protect the genome against oxidative damage.Hum Mol Genet2009;18:4102-17

[80] Seidle HF,Brenner C.Disease-associated mutations inactivate AMP-lysine hydrolase activity of Aprataxin.J Biol Chem2005;280:20927-31 PMCID:PMC2556069

[81] Hoch NC,Rulten SL.Care4Rare Canada ConsortiumXRCC1 mutation is associated with PARP1 hyperactivation and cerebellar ataxia.Nature2017;541:87-91 PMCID:PMC5218588

[82] Altmann T.DNA ligase IV syndrome; a review.Orphanet J Rare Dis2016;11:137 PMCID:PMC5055698

[83] Tilgner K,Singhapol C.Brief report: a human induced pluripotent stem cell model of cernunnos deficiency reveals an important role for XLF in the survival of the primitive hematopoietic progenitors.Stem Cells2013;31:2015-23

[84] Guo C,Woodbine L.XRCC4 deficiency in human subjects causes a marked neurological phenotype but no overt immunodeficiency.J Allergy Clin Immunol2015;136:1007-17

[85] Kennedy BK,Brunet A.Geroscience: linking aging to chronic disease.Cell2014;159:709-13 PMCID:PMC4852871

[86] Natale V.A comprehensive description of the severity groups in Cockayne syndrome.Am J Med Genet A2011;155A:1081-95

[87] Laugel V.Cockayne syndrome: the expanding clinical and mutational spectrum.Mech Ageing Dev2013;134:161-70

[88] Andressoo JO.Transcription-coupled repair and premature ageing.Mutat Res2005;577:179-94

[89] Vermeulen W,Jaspers NG.A temperature-sensitive disorder in basal transcription and DNA repair in humans.Nat Genet2001;27:299-303

[90] de Boer J,de Wit J.Premature aging in mice deficient in DNA repair and transcription.Science2002;296:1276-9

[91] Wijnhoven SW,Roodbergen M.Accelerated aging pathology in ad libitum fed Xpd(TTD) mice is accompanied by features suggestive of caloric restriction.DNA Repair (Amst)2005;4:1314-24

[92] van der Pluijm I,Brandt RM.Impaired genome maintenance suppresses the growth hormone - insulin-like growth factor 1 axis in mice with Cockayne syndrome.PLoS Biol2007;5:e2 PMCID:PMC1698505

[93] Kraemer KH,Scotto J.Xeroderma pigmentosum. Cutaneous, ocular, and neurologic abnormalities in 830 published cases.Arch Dermatol1987;123:241-50

[94] Brooks PJ.The 8,5’-cyclopurine-2’-deoxynucleosides: candidate neurodegenerative DNA lesions in xeroderma pigmentosum, and unique probes of transcription and nucleotide excision repair.DNA Repair (Amst)2008;7:1168-79 PMCID:PMC2797313

[95] Sidorova JM.Human RECQ helicases: roles in cancer, aging, and inherited disease.Adv Genomics Genet2014;5:19-33

[96] Root H,Komosa M.FANCD2 limits BLM-dependent telomere instability in the alternative lengthening of telomeres pathway.Hum Mol Genet2016;25:3255-68

[97] Wietmarschen N, Merzouk S, Halsema N, Spierings DCJ, Guryev V, Lansdorp PM. BLM helicase suppresses recombination at G-quadruplex motifs in transcribed genes.Nat Commun2018;9:271 PMCID:PMC5773480

[98] Luong TT.Role and regulation of the RECQL4 family during genomic integrity maintenance.Genes (Basel)2021;12:1919 PMCID:PMC8701316

[99] Liu FJ,Opresko PL.The Werner syndrome protein suppresses telomeric instability caused by chromium (VI) induced DNA replication stress.PLoS ONE2010;5:e11152 PMCID:PMC2886837

[100] Hanada K.Molecular genetics of RecQ helicase disorders.Cell Mol Life Sci2007;64:2306-22

[101] Croteau DL,Hoh Ferrarelli L,Bohr VA.RECQL4 in genomic instability and aging.Trends Genet2012;28:624-31 PMCID:PMC3500627

[102] Kudlow BA,Monnat RJ Jr.Werner and Hutchinson-Gilford progeria syndromes: mechanistic basis of human progeroid diseases.Nat Rev Mol Cell Biol2007;8:394-404

[103] Schatz DG.Recombination centres and the orchestration of V(D)J recombination.Nat Rev Immunol2011;11:251-63

[104] Villartay JP, Fischer A, Durandy A. The mechanisms of immune diversification and their disorders.Nat Rev Immunol2003;3:962-72

[105] Bohgaki M,El Ghamrasni S.RNF168 ubiquitylates 53BP1 and controls its response to DNA double-strand breaks.Proc Natl Acad Sci USA2013;110:20982-7 PMCID:PMC3876264

[106] Lieber MR.The mechanism of double-strand DNA break repair by the nonhomologous DNA end-joining pathway.Annu Rev Biochem2010;79:181-211 PMCID:PMC3079308

[107] Keim C,Rothschild G.Regulation of AID, the B-cell genome mutator.Genes Dev2013;27:1-17 PMCID:PMC3553278

[108] Villartay J, Poinsignon C, de Chasseval R, Buck D, Le Guyader G, Villey I. Human and animal models of V(D)J recombination deficiency.Curr Opin Immunol2003;15:592-8

[109] Villartay JP. Congenital defects in V(D)J recombination.Br Med Bull2015;114:157-67

[110] Felgentreff K,Frugoni F.Functional analysis of naturally occurring DCLRE1C mutations and correlation with the clinical phenotype of ARTEMIS deficiency.J Allergy Clin Immunol2015;136:140-150.e7 PMCID:PMC4494888

[111] Durandy A,Peron S.Pathophysiology of B-cell intrinsic immunoglobulin class switch recombination deficiencies.Adv Immunol2007;94:275-306

[112] Qamar N.The hyper IgM syndromes.Clin Rev Allergy Immunol2014;46:120-30

[113] Casellas R,Yewdell WT,Robbiani DF.Mutations, kataegis and translocations in B cells: understanding AID promiscuous activity.Nat Rev Immunol2016;16:164-76 PMCID:PMC4871114

[114] Kracker S,Durandy A.Inherited defects of immunoglobulin class switch recombination.Adv Exp Med Biol2010;685:166-74

[115] Wimmer K,Vasen HF.Diagnostic criteria for constitutional mismatch repair deficiency syndrome: suggestions of the European consortium ‘care for CMMRD’ (C4CMMRD).J Med Genet2014;51:355-65

[116] Stewart GS,Townsend K.The RIDDLE syndrome protein mediates a ubiquitin-dependent signaling cascade at sites of DNA damage.Cell2009;136:420-34

[117] Chrzanowska KH,Dembowska-Bagińska B,Digweed M.Nijmegen breakage syndrome (NBS).Orphanet J Rare Dis2012;7:13 PMCID:PMC3314554

[118] Specks J,Lopez-contreras AJ.Modeling the study of DNA damage responses in mice.Methods Mol Biol2015;1267:413-37 PMCID:PMC4878652

[119] Elson A,Daugherty CJ.Pleiotropic defects in ataxia-telangiectasia protein-deficient mice.Proc Natl Acad Sci USA1996;93:13084-9 PMCID:PMC24050

[120] Herzog KH,Kapsetaki M,McKinnon PJ.Requirement for Atm in ionizing radiation-induced cell death in the developing central nervous system.Science1998;280:1089-91

[121] Xu Y.Dual roles of ATM in the cellular response to radiation and in cell growth control.Genes Dev1996;10:2401-10

[122] Spring K,Li C.Atm knock-in mice harboring an in-frame deletion corresponding to the human ATM 7636del9 common mutation exhibit a variant phenotype.Cancer Res2001;61:4561-68

[123] Tal E,Zha S.Inactive Atm abrogates DSB repair in mouse cerebellum more than does Atm loss, without causing a neurological phenotype.DNA Repair (Amst)2018;72:10-7 PMCID:PMC7985968

[124] Lavin MF.The appropriateness of the mouse model for ataxia-telangiectasia: neurological defects but no neurodegeneration.DNA Repair (Amst)2013;12:612-9

[125] Perez H,Chavira JI.A novel, ataxic mouse model of ataxia telangiectasia caused by a clinically relevant nonsense mutation.Elife2021;10:e64695 PMCID:PMC8601662

[126] Hakem R,Sirard C.The Tumor Suppressor Gene Brca1 Is Required for Embryonic Cellular Proliferation in the Mouse.Cell1996;85:1009-23

[127] Liu X,van der Gulden H.Somatic loss of BRCA1 and p53 in mice induces mammary tumors with features of human BRCA1-mutated basal-like breast cancer.Proc Natl Acad Sci USA2007;104:12111-6 PMCID:PMC1924557

[128] Xu X,Larson D.Conditional mutation of Brca1 in mammary epithelial cells results in blunted ductal morphogenesis and tumour formation.Nat Genet1999;22:37-43

[129] Drost R,Rottenberg S.BRCA1 RING function is essential for tumor suppression but dispensable for therapy resistance.Cancer Cell2011;20:797-809

[130] Wind N, Dekker M, Berns A, Radman M, te Riele H. Inactivation of the mouse Msh2 gene results in mismatch repair deficiency, methylation tolerance, hyperrecombination, and predisposition to cancer.Cell1995;82:321-30

[131] Wind N, Dekker M, van Rossum A, van der Valk M, Te Riele H. Mouse models for hereditary nonpolyposis colorectal cancer.Cancer Res1998;58:248-255

[132] Chester N,Kozak C,Leder P.Stage-specific apoptosis, developmental delay, and embryonic lethality in mice homozygous for a targeted disruption in the murine Bloom’s syndrome gene.Genes Dev1998;12:3382-93 PMCID:PMC317228

[133] Cheng NC,van der Valk MA.Mice with a targeted disruption of the Fanconi anemia homolog Fanca.Hum Mol Genet2000;9:1805-11

[134] Whitney MA,Low MJ.Germ cell defects and hematopoietic hypersensitivity to gamma-interferon in mice with a targeted disruption of the Fanconi anemia C gene.Blood1996;88:49-58

[135] Carreau M,Liu L,McKerlie C.Bone marrow failure in the Fanconi anemia group C mouse model after DNA damage.Blood1998;91:2737-44

[136] Chang S,Cabrera NG.Essential role of limiting telomeres in the pathogenesis of Werner syndrome.Nat Genet2004;36:877-82

[137] Eriksson M,Gordon LB.Recurrent de novo point mutations in lamin A cause Hutchinson-Gilford progeria syndrome.Nature2003;423:293-8

[138] Liu B,Chan KM.Genomic instability in laminopathy-based premature aging.Nat Med2005;11:780-5

[139] Alderton GK,Varon R,Jeggo PA.Seckel syndrome exhibits cellular features demonstrating defects in the ATR-signalling pathway.Hum Mol Genet2004;13:3127-38

[140] Murga M,Montaña MF.A mouse model of ATR-Seckel shows embryonic replicative stress and accelerated aging.Nat Genet2009;41:891-8 PMCID:PMC2902278

[141] Murai M,Inamura N.Early postnatal ataxia and abnormal cerebellar development in mice lacking Xeroderma pigmentosum Group A and Cockayne syndrome Group B DNA repair genes.Proc Natl Acad Sci USA2001;98:13379-84 PMCID:PMC60879

[142] Van der Horst GT,Berg RJ.Defective Transcription-Coupled Repair in Cockayne Syndrome B Mice Is Associated with Skin Cancer Predisposition.Cell1997;89:425-35

[143] Zhu J,Tessarollo L.Targeted disruption of the Nijmegen breakage syndrome gene NBS1 leads to early embryonic lethality in mice.Curr Biol2001;11:105-9

[144] Kang J,Xu Y.Targeted disruption of NBS1 reveals its roles in mouse development and DNA repair.EMBO J2002;21:1447-55 PMCID:PMC125926

[145] Frappart PO,Demuth I.An essential function for NBS1 in the prevention of ataxia and cerebellar defects.Nat Med2005;11:538-44

[146] Yang YG,Frappart L,Tong WM.A novel function of DNA repair molecule Nbs1 in terminal differentiation of the lens fibre cells and cataractogenesis.DNA Repair (Amst)2006;5:885-93

[147] Assaf Y,Shapira I.MRI evidence of white matter damage in a mouse model of Nijmegen breakage syndrome.Exp Neurol2008;209:181-91

[148] Baranes K,Nitzan A.Conditional inactivation of the NBS1 gene in the mouse central nervous system leads to neurodegeneration and disorganization of the visual system.Exp Neurol2009;218:24-32

[149] Galron R,Lifshitz V.Astrocyte dysfunction associated with cerebellar attrition in a Nijmegen breakage syndrome animal model.J Mol Neurosci2011;45:202-11

[150] Martin LJ.DNA damage response and repair, DNA methylation, and cell death in human neurons and experimental animal neurons are different.J Neuropathol Exp Neurol2018;77:636-55 PMCID:PMC6005106

[151] Li J,Pembroke WG.Conservation and divergence of vulnerability and responses to stressors between human and mouse astrocytes.Nat Commun2021;12:3958 PMCID:PMC8233314

[152] Gatti RA. Ataxia Telangiectasia. 600-606 (Lippincott Williams & Wilkins, 2003). Available from: https://www.derm.theclinics.com/article/S0733-8635(18)30100-1/pdf [Last accessed on 9 May 2022].

[153] Stewart GS,Stankovic T.The DNA double-strand break repair gene hMRE11 is mutated in individuals with an ataxia-telangiectasia-like disorder.Cell1999;99:577-87

[154] Gennery AR,Jeggo PA.Immunodeficiency associated with DNA repair defects.Clin Exp Immunol2000;121:1-7 PMCID:PMC1905662

[155] Niraj J,D’Andrea AD.The Fanconi anemia pathway in cancer.Annu Rev Cancer Biol2019;3:457-78 PMCID:PMC6417835

[156] Katsuki Y.Defects in homologous recombination repair behind the human diseases: FA and HBOC.Endocr Relat Cancer2016;23:T19-37

[157] Prakash R,Feng W.Homologous recombination and human health: the roles of BRCA1, BRCA2, and associated proteins.Cold Spring Harb Perspect Biol2015;7:a016600 PMCID:PMC4382744

[158] Fishel R,Rao M.The human mutator gene homolog MSH2 and its association with hereditary nonpolyposis colon cancer.Cell1993;75:1027-38

[159] Parsons R,Longley MJ.Hypermutability and mismatch repair deficiency in RER+ tumor cells.Cell1993;75:1227-36

[160] Ryan E,Creavin B,Winter DC.The current value of determining the mismatch repair status of colorectal cancer: A rationale for routine testing.Crit Rev Oncol Hematol2017;116:38-57

[161] de Andrade KC,Wegman-Ostrosky T.Variable population prevalence estimates of germline TP53 variants: a gnomAD-based analysis.Hum Mutat2019;40:97-105 PMCID:PMC6296902

[162] Wiesmüller L,Schiestl RH.DNA damage, repair, and diseases.J Biomed Biotechnol2002;2:45 PMCID:PMC153783

[163] Al-Tassan N,Maynard J.Inherited variants of MYH associated with somatic G:C-->T:A mutations in colorectal tumors.Nat Genet2002;30:227-32

[164] Weren RD,Kets CM.A germline homozygous mutation in the base-excision repair gene NTHL1 causes adenomatous polyposis and colorectal cancer.Nat Genet2015;47:668-71

[165] Grover S,Steyerberg EW.Prevalence and phenotypes of APC and MUTYH mutations in patients with multiple colorectal adenomas.JAMA2012;308:485-92 PMCID:PMC3770297

[166] Carney JP,Olivares H.The hMre11/hRad50 protein complex and nijmegen breakage syndrome: linkage of double-strand break repair to the cellular DNA damage response.Cell1998;93:477-86

[167] Matsuura S,Nakamura A.Positional cloning of the gene for Nijmegen breakage syndrome.Nat Genet1998;19:179-81

[168] Oshima J,Monnat RJ Jr.Werner syndrome: clinical features, pathogenesis and potential therapeutic interventions.Ageing Res Rev2017;33:105-14 PMCID:PMC5025328

[169] Chen L.Werner syndrome.J Biomed Biotechnol2002;2:46-54 PMCID:PMC153784

[170] Lehmann J,Martens MC.Xeroderma pigmentosum - facts and perspectives.Anticancer Res2018;38:1159-64

[171] Sharma R,Wlodarski MW.DNA repair syndromes and cancer: insights Into genetics and phenotype patterns.Front Pediatr2020;8:570084 PMCID:PMC7644847

[172] Crow YJ.Aicardi-goutières syndrome. NBK1475 1993.

[173] Livingston JH.Neurologic phenotypes associated with mutations in TREX1, RNASEH2A, RNASEH2B, RNASEH2C, SAMHD1, ADAR1, and IFIH1: aicardi-goutières syndrome and beyond.Neuropediatrics2016;47:355-60

[174] Moreira MC.Ataxia with oculomotor apraxia type 2. NBK1154. 1993.

[175] Anheim M,Fleury M.Ataxia with oculomotor apraxia type 2: clinical, biological and genotype/phenotype correlation study of a cohort of 90 patients.Brain2009;132:2688-98

[176] Laugel V,Tobias ES.Cerebro-oculo-facio-skeletal syndrome: three additional cases with CSB mutations, new diagnostic criteria and an approach to investigation.J Med Genet2008;45:564-71

[177] Le Van Quyen P,Bonnière M.Prenatal diagnosis of cerebro-oculo-facio-skeletal syndrome: Report of three fetuses and review of the literature.Am J Med Genet A2020;182:1236-42

[178] Karikkineth AC,Fivenson E,Bohr VA.Cockayne syndrome: clinical features, model systems and pathways.Ageing Res Rev2017;33:3-17 PMCID:PMC5195851

[179] Savage SA.Dyskeratosis congenita.Hematol Oncol Clin North Am2009;23:215-31 PMCID:PMC2702847

[180] Dumitrache LC.Polynucleotide kinase-phosphatase (PNKP) mutations and neurologic disease.Mech Ageing Dev2017;161:121-9 PMCID:PMC5161711

[181] Reynolds JJ,Gilmore EC,Caldecott KW.Impact of PNKP mutations associated with microcephaly, seizures and developmental delay on enzyme activity and DNA strand break repair.Nucleic Acids Res2012;40:6608-19 PMCID:PMC3413127

[182] Shen J,Marshall CA.Mutations in PNKP cause microcephaly, seizures and defects in DNA repair.Nat Genet2010;42:245-9 PMCID:PMC2835984

[183] O’Driscoll M,Woods CG,Goodship JA.A splicing mutation affecting expression of ataxia-telangiectasia and Rad3-related protein (ATR) results in Seckel syndrome.Nat Genet2003;33:497-501

[184] Saneto RP,Copeland WC.Alpers-Huttenlocher syndrome.Pediatr Neurol2013;48:167-78 PMCID:PMC3578656

[185] Harhouri K,Bartoli C,De Sandre-Giovannoli A.An overview of treatment strategies for Hutchinson-Gilford Progeria syndrome.Nucleus2018;9:246-57 PMCID:PMC5973194

[186] Hennekam RC.Hutchinson-Gilford progeria syndrome: review of the phenotype.Am J Med Genet A2006;140:2603-24

[187] Morio T.Recent advances in the study of immunodeficiency and DNA damage response.Int J Hematol2017;106:357-65

[188] Chistiakov DA.Ligase IV syndrome.Adv Exp Med Biol2010;685:175-85

[189] Morimoto M,Lucke T.Schimke Immunoosseous Dysplasia. NBK1376 1993.